On the stock market since 1980, it operates in the world of health and science. It has 712 employees. Now — the numbers.
This is an established company with proven profits.
The biggest line carries real weight, but it doesn’t decide everything on its own.
No real growth (2% a year).
If every debt were paid off today, $6.0M would still be left in the vault — a solid cushion for hard times.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
There is $6.3M in the vault; even if every debt were paid off, $6.0M would remain.
It pays out $8.80 per share each year — regular cash for whoever holds the stock.
The company’s market value is 42 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn.
On our five-subject report card, ATRI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ATRI is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.